D Huw Davies Selected Research

D Huw Davies Research Topics

Disease

28	Infections 11/2021 - 01/2005
13	Malaria 01/2019 - 07/2006
9	Vaccinia 10/2021 - 01/2005
4	Human Influenza (Influenza) 01/2022 - 12/2018
3	COVID-19 11/2021 - 05/2020
3	Communicable Diseases (Infectious Diseases) 01/2018 - 02/2010
3	Typhoid Fever (Typhoid) 01/2017 - 01/2013
3	Tularemia 01/2016 - 06/2005
3	Toxoplasmosis 05/2015 - 02/2007
2	Tuberculosis (Tuberculoses) 07/2019 - 05/2015
2	Virus Diseases (Viral Diseases) 12/2018 - 03/2013
2	Smallpox (Variola) 03/2012 - 05/2007
1	Bacillary Dysentery (Shigellosis) 01/2021
1	Papilloma (Papillomatosis) 01/2021
1	Poliomyelitis (Polio) 01/2021
1	Q Fever (Fever, Q) 01/2021
1	Parasitemia 01/2019
1	Bites and Stings (Sting) 03/2016
1	Fever (Fevers) 03/2016
1	Reinfection 11/2015
1	Asymptomatic Infections 02/2015
1	Herpes Genitalis (Genital Herpes) 04/2012
1	Bacteremia 03/2012
1	Salmonella Infections (Salmonellosis) 03/2012
1	Persistent Infection 07/2011
1	Condylomata Acuminata (Genital Wart) 09/2010
1	Carcinoma (Carcinomatosis) 09/2010
1	Neoplasms (Cancer) 09/2010
1	Melioidosis 08/2009
1	Bacterial Infections (Bacterial Infection) 08/2009
1	Lyme Disease (Disease, Lyme) 08/2008
1	Falciparum Malaria (Plasmodium falciparum Malaria) 07/2006
1	Rheumatoid Arthritis 12/2004
1	Arthritis (Polyarthritis) 12/2004

Drug/Important Bio-Agent (IBA)

33	AntigensIBA 11/2021 - 01/2005
28	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2005
20	VaccinesIBA 01/2022 - 01/2005
16	AntibodiesIBA 10/2021 - 08/2008
11	ProteomeIBA 01/2018 - 01/2005
9	Immunoglobulin G (IgG)IBA 11/2021 - 07/2011
6	Immunoglobulin M (IgM)IBA 01/2018 - 07/2011
4	Immunoglobulin A (IgA)IBA 12/2018 - 01/2016
3	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 10/2021 - 09/2005
3	Subunit VaccinesIBA 03/2012 - 02/2010
2	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 01/2019
2	NucleoproteinsIBA 01/2021 - 05/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2013
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2019 - 12/2015
2	EpitopesIBA 12/2018 - 06/2008
2	LipopolysaccharidesIBA 06/2017 - 01/2016
2	Hemolysin Proteins (Hemolysins)IBA 06/2017 - 01/2016
2	Recombinant ProteinsIBA 05/2015 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 08/2008 - 02/2007
1	Messenger RNA (mRNA)IBA 11/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2021
1	Combined VaccinesIBA 01/2021
1	Disinfectants (Biocides)IBA 01/2021
1	Neuraminidase (Sialidase)IBA 01/2019
1	Collodion (Nitrocellulose)IBA 01/2019
1	Chloroquine (Aralen)FDA LinkGeneric 01/2019
1	2- (N- phenethyl- N- propyl)amino- 5- hydroxytetralinIBA 01/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	Antimalarials (Antimalarial Agents)IBA 11/2015
1	UbiquitinIBA 05/2015
1	TransferasesIBA 05/2015
1	Viral ProteinsIBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 04/2012
1	Immune Sera (Antisera)IBA 03/2012
1	ImmunosorbentsIBA 03/2012
1	EnzymesIBA 03/2012
1	Peptides (Polypeptides)IBA 07/2011
1	CytokinesIBA 08/2009
1	HLA-DR Antigens (HLA-DR)IBA 08/2009
1	Immunodominant EpitopesIBA 05/2007
1	DNA VaccinesIBA 02/2007
1	Codon (Codons)IBA 02/2007
1	AutoantigensIBA 12/2004
1	Collagen Type II (Type II Collagen)IBA 12/2004

Therapy/Procedure

1	Chemoprevention 01/2019
1	Mass Drug Administration 01/2017
1	Therapeutics 01/2011
1	Mucosal Administration 12/2004